Laboratory adaptations - Changing expectations

Clinical Chemistry

Volumn 47, Issue 8, 2001, Pages 1509-1515

  Kisabeth, R M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER;

CLINICAL CHEMISTRY; CLINICAL LABORATORY; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEALTH CARE QUALITY; IMMUNOASSAY; MEDICAL DECISION MAKING; MEDICAL INSTRUMENTATION; PATIENT CARE; PHARMACOGENETICS; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0034921958     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.8.1509     Document Type: Conference Paper

References (44)

1. Surgery of the sympathetic nervous system
2. Accuracy in clinical chemistry - Does anybody care?
3. The village that voted the earth was flat
4. A conceptual model for establishing tolerance limits for analytical bias and imprecision based on variations in population test distributions
5. Analytic bias specifications based on the analysis of effects on performance of medical guidelines
6. Optimal procedures for detecting analytic bias using patient samples
7. Reference reagents for prostate-specific antigen (PSA): Establishment of the First International Standards for free PSA and PSA (90:10)
8. Cholesterol - A model system to relate medical needs with analytical performance
9. A reference method laboratory network for cholesterol: A model for standardization and improvement of clinical laboratory measurements
10. Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid
11. Methylmalonic acid measured in plasma and urine by stable-isotope dilution and electrospray tandem mass spectrometry
12. Anti-ssDNA not useful, withdrawn from survey
13. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
14. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
15. Endothelium-derived relaxing factor and coronary vasospasm
16. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
17. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients
18. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
19. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis
20. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [Special Article]
21. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
22. Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells
23. CTLA4lg-mediated blockage of T-cell costimulation in patients with psoriasis vulgaris
24. Molecular fingerprint of interferon-γ signaling in unstable angina
25. Increased expression of Fc γ receptors on neutrophils and monocytes may reflect ongoing bacterial infection
26. CD64 in febrile illness
27. Neutrophil CD64 expression: Potential diagnostic indicator of acute inflammation and therapeutic monitor of interferon-γ therapy
28. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
29. Unsupervised knowledge discovery in medical databases using relevance networks
30. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks
31. Quantitative drug interactions prediction system (Q-DIPS): A computer-based prediction and management support system for drug metabolism interactions
32. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiple long PCR
33. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
34. Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development
35. Clinical impact of rapid in vitro susceptibility testing and bacterial identification
36. Monitoring protein expression in whole bacterial cells with MALDI time-of-flight mass spectrometry
37. MALDI-TOF MS sequencing of oligonucleotides containing oxidative lesions
38. Molecular and immunological detection of circulating tumor cells and micrometastasis from solid tumors
39. Quantification of melanoma cell-specific MART-1 mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR
40. Pharmacogenomics: A clinician's primer on emerging technologies for improved patient care
41. Radical operations on the stomach with especial reference to mobilization of the lesser curvature